期刊文献+

脉搏波传导速度、踝臂指数和高敏C-反应蛋白与冠心病的相关性研究 被引量:7

下载PDF
导出
摘要 目的分析冠心病的发病率与肱-踝脉搏波传导速度(BaPWV)、踝臂指数(ABI)及高敏C-反应蛋白(hs-CRP)的相关性。方法对241例可疑冠心病患者行冠状动脉造影(CAG)的同时检测BaPWV、ABI及hs-CRP,并对其结果进行对照性分析,同时行病史采集及其他常规化验检查,分析BaPWV、ABI、hs-CRP三者与冠心病高危人群发生冠心病的相关性。结果 BaPWV、hs-CRP在不同冠脉窄度各组间、不同冠脉支数各组间差异均有统计学意义(P<0.01);ABI在不同冠脉窄度、不同冠脉支数各组间差异均无统计学意义(P>0.05)。结论 BaPWV及hs-CRP与冠心病的发生具有强相关性,均可反映冠脉病变的严重程度,BaPWV及hs-CRP增加均是冠心病有意义的独立预测因子;ABI不管单因素还是多因素分析,在冠脉病变窄度、冠脉病变支数各组间均无相关性,不能反映冠脉病变的程度。
出处 《河北医药》 CAS 2013年第2期207-209,共3页 Hebei Medical Journal
  • 相关文献

参考文献3

二级参考文献18

  • 1Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arterial hypertension:The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) [J]. Eur Heart J,2007,28 : 1462 - 1536.
  • 2Weber MA, Julius S, Kjeldsen SE,et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trial[ J]. Lancet,2004,363:2049- 2051.
  • 3Pepine C J, Kowey PR, Kupfer S, et al. Predictors of adverse outcome among patients with hypertension and coronary artery disease [J]. J Am Coll Cardiol,2006,47:547 -551.
  • 4Julius S, Kjeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine:the VALUE randomised trial[ J ]. Lancet, 2004,363:2022 - 2031.
  • 5Dahlof B, Sever PS, Pouher NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomised controlled trial [J].Lancet,2005,366 : 895 - 906.
  • 6Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone:the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group [ J ]. Jama, 2000,283 : 1967 - 1975.
  • 7Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction : the CHARM-Preserved trial [ J ]. Lancet, 2003, 362:777 -781.
  • 8Criqui MH,Langer RD,Fronek A,et al.Mortality over a period of 10 years in patients with peripheral arterial disease[J].N Engl J Med,1992,326(6):381-386.
  • 9Migliacci R,Nasorri R,Ricciarini P,et al.Ankle-brachial index measured by palpation for the diagnosis of peripheral arterial disease[J].Fam Pract,2008,25(4):228-232.
  • 10Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality:a meta-analysis[J].JAMA,2008,300 (2):197-208.

共引文献171

同被引文献59

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部